Detalhe da pesquisa
1.
Sulopenem Disk Development, Quality Control Range, and MIC to Disk Result Correlation for Enterobacterales Isolates.
J Clin Microbiol
; 61(7): e0024623, 2023 07 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37358462
2.
CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests.
J Clin Microbiol
; 56(4)2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29367292
3.
Erratum for Humphries et al., "CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests".
J Clin Microbiol
; 61(10): e0073923, 2023 Oct 24.
Artigo
Inglês
| MEDLINE | ID: mdl-37732793
4.
Changes in the antibiotic susceptibility of anaerobic bacteria from 2007-2009 to 2010-2012 based on the CLSI methodology.
Anaerobe
; 42: 27-30, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27427465
5.
Analysis of the effect of urine on the in vitro activity of gepotidacin and levofloxacin against Escherichia coli, Staphylococcus epidermidis, and Staphylococcus saprophyticus.
Diagn Microbiol Infect Dis
; 106(3): 115946, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37201401
6.
Analysis of antimicrobial susceptibility testing methods and variables and in vitro activity of gepotidacin against urogenital Neisseria gonorrhoeae in men.
Diagn Microbiol Infect Dis
; 101(4): 115484, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34419740
7.
Activity of levofloxacin alone and in combination with a DnaK inhibitor against gram-negative rods, including levofloxacin-resistant strains.
Antimicrob Agents Chemother
; 53(2): 814-7, 2009 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-19015359
8.
1,3-Dioxane-Linked Bacterial Topoisomerase Inhibitors with Enhanced Antibacterial Activity and Reduced hERG Inhibition.
ACS Infect Dis
; 5(7): 1115-1128, 2019 07 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31041863
9.
Interpretive categorical accuracy of fluoroquinolone reference broth microdilution MIC results when testing Streptococcus pneumoniae: selection of a surrogate testing agent.
Diagn Microbiol Infect Dis
; 62(4): 460-3, 2008 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-18990533
10.
Determination of moxifloxacin anaerobic susceptibility breakpoints according to the Clinical and Laboratory Standards Institute guidelines.
Diagn Microbiol Infect Dis
; 61(1): 49-57, 2008 May.
Artigo
Inglês
| MEDLINE | ID: mdl-18342475
11.
Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
J Antimicrob Chemother
; 66(11): 2673-5, 2011 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-21846674
12.
Characterisation of carbapenem-resistant Enterobacteriaceae from the southwestern Ohio, northern Kentucky and southeastern Indiana region.
J Glob Antimicrob Resist
; 7: 141-144, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27835839
13.
Multi-center and multi-method evaluation of in vitro activities of ceftaroline against S. aureus.
Diagn Microbiol Infect Dis
; 85(4): 452-8, 2016 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-27233426
14.
Evolving concepts of pharmaceutical company-sponsored surveillance studies.
Clin Infect Dis
; 41 Suppl 4: S279-82, 2005 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-16032566
15.
A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically.
J Vis Exp
; (103)2015 Sep 09.
Artigo
Inglês
| MEDLINE | ID: mdl-26381422
16.
Comparison of daptomycin MIC results by DIN, NCCLS, SFM, and SRGA methods for 297 Gram-positive organisms.
Int J Antimicrob Agents
; 23(1): 17-24, 2004 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-14732309
17.
Streptococcus pneumoniae in vitro development of resistance to amoxicillin/clavulanic acid, cefaclor, levofloxacin and azithromycin.
Int J Antimicrob Agents
; 24(2): 144-9, 2004 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-15288313
18.
Comparative in vitro activity of gemifloxacin to other fluoroquinolones and non-quinolone agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the United States in 1999-2000.
Int J Antimicrob Agents
; 19(1): 33-7, 2002 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-11814765
19.
Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
Int J Infect Dis
; 8(6): 362-73, 2004 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-15494258
20.
Use of appropriate breakpoints in antimicrobial surveillance studies.
Clin Infect Dis
; 35(11): 1446-8; author reply 1448-9, 2002 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-12439815